|Who we work for||Developers (pharmaceutical, diagnostic, medical device)||Investors||Decision Makers|
|What we do||Analyzing and modeling early which impact can be expected on therapy outcome and cost.Testing the hypothesis with future decision makers and payers.||Assessing healthcare alternatives (HTA / health technology assessment).
Considering stakeholder perspectives (e.g. patients / citizens)
Platform for early influence on new products and services.
Networking with peers across boarders.
Platform for addressing current topics in healthcare related decision making
|Defining the targets in the development.Identifying the path to the market.Value dossiers and value dossier reviews||Setting priorities among the investment alternatives.|
Education and training – tailored to the need of the recipients
(e.g. health economic and outcomes research methods – international health policy – decision support / prioritization – quality assessment)
|What the goal is||… to improve the overall value balance of products and services in healthcare|
By knowing and integrating the perspectives of our customers, we balance and mediate their perceptions of value – early and throughout product development.